Stress-induced hyperglycemia is a fundamental adaptive response that mobilizes energy stores in response to threats. Here, our examination of the contributions of the central catecholaminergic (CA) neuronal system to this adaptive response revealed that CA neurons in the ventrolateral medulla (VLM) control stress-induced hyperglycemia. Ablation of VLM CA neurons abolished the hyperglycemic response to both physical and psychological stress, whereas chemogenetic activation of these neurons was sufficient to induce hyperglycemia. We further found that CA neurons in the rostral VLM, but not those in the caudal VLM, cause hyperglycemia via descending projections to the spinal cord. Monosynaptic tracing experiments showed that VLM CA neurons receive direct inputs from multiple stressresponsive brain areas. Optogenetic studies identified an excitatory PVN-VLM circuit that induces hyperglycemia. This study establishes the central role of VLM CA neurons in stress-induced hyperglycemia and substantially expands our understanding of the central mechanism that controls glucose metabolism.
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In Brief
Zhao et al. identified a neural circuit that controls blood glucose levels during stress. They demonstrate that VLM CA neurons integrate stress signals from multiple stress-related areas (e.g., the PVN) and cause hyperglycemia via descending projections to the spinal cord.
INTRODUCTION
Glucose is the main energy source for mammals. When facing significant threats (stressors), the body's glucose stores are mobilized, resulting in a rapid elevation of blood glucose levels. This stress-induced hyperglycemia provides a quickly accessible energy supply for animals in danger with which to undertake the proverbial fight-or-flight response, thereby promoting an individual's survival (Marik and Bellomo, 2013) . Many brain areas, including hypothalamic regions and the hindbrain, have previously been shown to regulate both blood glucose levels and stress responses (Ulrich-Lai and Ryan, 2014) . However, the key brain site responsible for stress-induced hyperglycemia has not been established.
Hindbrain catecholaminergic (CA) neurons (here referring specifically to norepinephrine and epinephrine neurons) are known to be highly responsive to various stressors, including immobilization and immune challenges (Ericsson et al., 1994; Kvetnansky et al., 2009; Morilak et al., 2005; Stanford, 1995) . The locus coeruleus (LC) is the major pool of central CA neurons. Electrophysiological recordings in freely moving cats showed that most LC CA neurons are activated by hypoglycemia and are inhibited following glucose administration (Morilak et al., 1987) , suggesting a role for LC CA neurons in glucoregulatory responses. Indeed, the LC-CA system has actually been proposed to drive the sympathetic nervous system and thereby cause stress-induced hyperglycemia (Marik and Bellomo, 2013) .
Outside the LC, CA neurons are also located in the nucleus tractus solitaries (NTS) and in the ventrolateral medulla (VLM) (Kfelt et al., 1974; Moore and Bloom, 1979) . Glucose-sensing neurons have been identified in the NTS (Adachi et al., 1995; Balfour et al., 2006) , and activation of NTS neurons expressing glucose transporter 2 increased glucagon secretion (Lamy et al., 2014) . VLM CA neurons have been previously shown to regulate hyperglycemia. Immunotoxic ablation of CA neurons in the rostral part of the VLM abrogates hyperglycemia, adrenaline secretion, and adrenal medullary Fos expression in response to the glucoprivic agent 2-deoxy-D-glucose (Madden et al., 2006; Ritter et al., 2001) . Local microinjection of the GABA A receptor antagonist bicuculline into the VLM induces hyperglycemia, an effect dependent on intact adrenal glands (Verberne and Sartor, 2010) . Although separate populations of CA neurons have been shown to be important in glucose homeostasis, the question of whether or not the central CA system is involved in stress-induced hyperglycemia remains open.
In the present study, we used a cell-type-specific ablation approach to survey the roles of three different populations (LC, NTS, and VLM) of central CA neurons in stress-induced hyperglycemia. Strikingly, we found that only the VLM CA population is indispensable in controlling stress-induced hyperglycemia. Moreover, the selective activation of VLM CA neurons induced hyperglycemia via descending projections to the spinal cord. We then mapped the whole-brain monosynaptic inputs of VLM CA neurons and found that these neurons receive direct inputs from many stress-related nuclei. Specifically, we found that the hypothalamic paraventricular nucleus (PVN) sends excitatory projections to the VLM and causes hyperglycemia.
RESULTS

VLM CA Neurons Are Essential in Mediating Both
Physical and Psychological Stress-Induced Hyperglycemia Stressors commonly used in animal studies are classified into at least two categories: physical stress (also referred to as homeostatic or systemic, e.g., infection) and psychological stress (also referred to as emotional or neurogenic, e.g., footshock or restraint) (Dayas et al., 2001; Pacá k and Palkovits, 2001) . While some brain areas are known to be activated by both types of stress, neural circuits involved in processing stress responses are category specific (Dayas et al., 2001; Sawchenko et al., 2000) . To examine whether the CA neural system is important in mediating stress-induced hyperglycemia, we initially challenged animals with a physical stressor, bacterial lipopolysaccharide (LPS), to induce acute hyperglycemia; LPS has a long history of use as an immune stress treatment (Lang et al., 1985) . Injection of LPS significantly increased blood glucose levels in C57BL/6J mice ( Figure 1A ), confirming the suitability of LPS for inducing acute hyperglycemia. To check whether the CA neural system is activated by LPS challenge, Fos expression was examined as an indicator of neuronal activation. Immunoreactivity to tyrosine hydroxylase (TH) was used as a marker of hindbrain CA neuron identity. Following LPS challenge, Fos expression was observed within subsets of TH-immunoreactive neurons, including those in the LC, NTS, and VLM ( Figure 1B ), suggesting that these groups of CA neurons are responsive to LPS stress signals.
We next checked whether the neuronal activity of these CA neurons is required for the manifestation of LPS-induced hyperglycemia by performing a loss-of-function study that used a genetic approach to ablate particular CA neuronal populations in adult mice. Briefly, a Cre-dependent AAV vector encoding a genetically engineered Casp3 gene (AAV-flex-taCsap3-TEVp) was bilaterally injected into the LC, NTS, or VLM of Dbh-Cre transgenic mice (referred to as Dbh-LC Casp3 , Dbh-NTS Casp3 , and Dbh-VLM Casp3 mice, respectively) ( Figure 1C ). Casp3 activation has been shown to induce cell apoptosis (Yang et al., 2013; Zhang et al., 2016) . Dbh-Cre mice express the Cre recombinase under the control of the promoter the dopamine-b-hydroxylase (Dbh) gene. Dbh is a rate-limiting enzyme for the synthesis of the catecholamines NE and E and is expressed only in CA cells (Gerfen et al., 2013 Figure 1D ), demonstrating the anatomical precision of the ablation. We then examined whether the ablation of CA neurons affected stress-induced hyperglycemia. Although the LC is known to be the major CA neuronal pool and has for a long time been implicated in stress responses (Aston-Jones and Bloom, 1981) , the bilateral ablation of LC CA neurons had no significant effect on LPS-induced hyperglycemia ( Figure 1E, left) . Similarly, the ablation of NTS CA neurons did not alter LPSinduced hyperglycemia ( Figure 1E , middle). In contrast, the selective ablation of VLM CA neurons eliminated the expected LPS-induced hyperglycemia ( Figure 1E , right). Interestingly, mice lacking VLM CA neurons exhibit hypoglycemia after LPS treatments, suggesting that energy stores may not be quickly mobilized to restore the glucose that is consumed by the A) Immune stress (LPS, 10 mg/kg bodyweight, IP injection, black arrowhead) induced an acute hyperglycemic response. Control mice (saline, IP injection) did not exhibit hyperglycemia. **p < 0.01, ****p < 0.0001; two-way ANOVA analyses followed by Bonferroni's post hoc test. Data represent means + SEM in this and following figures. (B) Injection of LPS, but not saline, elicited Fos expression (red) in tyrosine hydroxylase (TH)-expressing neurons (green) within the LC, NTS, and VLM. Expression of TH is a marker for hindbrain catecholaminergic (CA) neurons. Fos and TH double-labeled cell number: 74 ± 5 (LPS) versus 1 ± 0.5 (saline) in the LC; 194 ± 8 (LPS) versus 3.5 ± 1 (saline) in the NTS; 289 ± 5 (LPS) versus 11 ± 3 (saline) in the VLM; n = 3 mice for each group. Scale bar: 50 mm. (C) Cartoon illustrating the loss-of-function strategy used in this study. (D) CA neurons restricted within the LC (left), NTS (middle), or VLM (right) were selectively ablated following injection of AAV-flex-Casp3-TEVp. TH immunostaining (green) was performed to confirm the ablation. White rectangular areas in each image show zoomed-in views of the areas indicated by arrows. (E) Ablating CA neurons in the VLM (right), but not the LC (left) or the NTS (middle), eliminated LPS-induced hyperglycemia. *p < 0.05, ***p < 0.001; two-way ANOVA analyses followed by Bonferroni's post hoc test between Dbh-VLM Casp3 and Dbh-VLM mCherry mice following LPS treatment.
See also Figure S1 .
immune system. Note that VLM-ablation had no significant effect on basal blood glucose levels (7. To examine whether VLM CA neurons are required for mediating hyperglycemic responses caused by psychological stressors, we challenged mice both with electric footshock and with restraint stress. Both brief footshock (0.5 mA, 2 s duration with a 6 s interval, for 3 min) and restraint (1 hr) activated VLM CA neurons (Figure 2A ). These results suggest that VLM CA neurons also process psychological stress-induced responses. Importantly, ablation of VLM CA neurons abolished both footshock-and restraint-induced hyperglycemia (Figures 2B and 2C) . The ablation of CA neurons in the LC or the NTS had no effect on footshock-induced hyperglycemia (Figures S1B and S1C). Our LPS, footshock, and restraint results all support the conclusion that VLM CA neurons are essential for stress-induced hyperglycemia.
We next asked whether silencing VLM CA neurons without ablating them can block stress-induced hyperglycemia. A Cre-dependent AAV vector encoding the Guillardia theta anion channelrhodopsin1 (GtACR1) (Govorunova et al., 2015) , a recently developed optogenetic inhibition tool, was bilaterally injected into the VLM of Dbh-Cre mice ( Figure 3A ). Blue light (473 nm) illumination could robustly silence GtACR1/GFP-positive neurons, and these neurons could recover to their basal firing rate within 3 s after photostimulation (Figures 3B and 3C) . Moreover, photostimulation of GtACR1-expressing neurons did not significantly alter the resting membrane potential (À71.7 ± 4.5 mV pre laser illumination versus À73.1 ± 4.1 mV post laser illumination, n = 4 neurons, mean ± SEM) ( Figure 3D ). Consistent with our ablation results, light inhibition of VLM CA neurons largely blocked hyperglycemic responses under all three of the stress treatments ( Figures 3E and 3F ), further confirming that VLM CA neurons are necessary for stress-induced hyperglycemia.
Activation of VLM CA Neurons Is Sufficient to Increase Blood Glucose Levels To examine whether direct activation of VLM CA neurons alone can increase blood glucose levels, we used the DREADD method (designer receptors exclusively activated by designer drugs) to selectively activate these neurons (Alexander et al., 2009) . A Cre-dependent AAV vector encoding both the hM3Dq receptor (a high-affinity receptor for the pharmacologically inert ligand clozapine-N-oxide [CNO] ) and the red fluorescent protein mCherry (AAV-DIO-hM3Dq-mCherry) was injected into the VLM of Dbh-Cre mice (Dbh-VLM hM3Dq mice) ( Figure 4A ). The hM3Dq/ mCherry signals were colocalized with TH immunoreactivity in the majority (>95%, 3,670 neurons from 5 Dbh-VLM hM3Dq mice) of VLM neurons ( Figure 4B ). Following CNO administration, Fos expression and Ca 2+ transients in hM3Dq/mCherry-expressing neurons confirmed the suitability of the DREADD method for the experimental activation of VLM CA neurons, both in vivo and in vitro ( Figures 4C and S2 , see also STAR Methods). We examined whether the activation of VLM CA neurons affects blood glucose levels. IP injection of CNO into Dbh-VLM hM3Dq mice significantly increased blood glucose levels within 30 min. Owing to the relatively long duration of the pharmacological action of CNO (Alexander et al., 2009) , glucose levels continued to rise, reaching a plateau within 2 hr ( Figure 4D ), before returning to baseline within 6 hr (data not shown). In contrast, the injection of saline did not alter blood glucose levels in Dbh-VLM hM3Dq mice. As an additional control, the injection of CNO into Dbh-VLM mCherry mice did not alter blood glucose levels either ( Figure 4D ). The selective activation of CA neurons in the LC or NTS did not increase blood glucose levels ( Figure S3 ). These results strongly support the notion that VLM CA neurons are sufficient to induce hyperglycemia.
The Adrenal Glands Serve as Peripheral Mediators of VLM CA Neurons in Controlling Stress-Induced Hyperglycemia It is well known that stress increases blood glucose levels by stimulating the release of stress hormones from the adrenal glands. We examined whether VLM CA neurons control glucose levels by regulating the activity of the adrenal glands. Chemogenetic activation of VLM CA neurons significantly increased serum epinephrine and corticosterone levels (Figures 4E). Following the bilateral removal of the adrenal glands from Dbh-VLM hM3Dq mice, the basal epinephrine and corticosterone levels in adrenalectomized mice were extremely low, and injection of CNO did not increase the levels of either stress hormone ( Figure 4F ). Importantly, bilateral adrenalectomy completely blocked the hyperglycemia elicited by activating VLM CA neurons (Figure 4G) . There was no significant difference in the blood glucose levels between CNO-and saline-treated adrenalectomized Dbh-VLM hM3Dq mice (two-way ANOVA: Time F(4,48) = 0.1846, p = 0.9453; injections F(1,12) = 1.741, p = 0.2116; interaction between time and injections F(4,48) = 1.242, p = 0.3059). Consistent with these chemogenetic activation results, the ablation of VLM CA neurons nearly abolished the stress-induced increases of these two hormones ( Figure 4H ). These results show that (F) Light inhibition of VLM CA neurons largely blocked LPS-(left), footshock-(middle), and restraint-(right) induced hyperglycemia. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; two-way ANOVA analyses followed by Bonferroni's post hoc test.
the adrenal glands can be viewed as peripheral, downstream effectors of VLM CA neurons in mediating stress-induced hyperglycemia.
VLM CA Neurons Increase Blood Glucose Levels via Descending Projections to the Spinal Cord
To identify neural circuits recruited by VLM CA neurons to increase blood glucose levels, we used a Cre-dependent, celltype-specific anterograde AAV viral tracer (AAV-DIO-mGFP) to examine the projection patterns of these neurons (Figures 5A and 5B). VLM CA neurons send outputs to 28 brain areas, including intense projections in the spinal intermediolateral nucleus (IML), the NTS, the LC, the dorsomedial hypothalamic nucleus, the paraventricular thalamic nucleus, the PVN, and the (1 mg/kg bodyweight, IP) or saline. ***p < 0.001, ****p < 0.0001; two-way ANOVA analyses followed by Bonferroni's post hoc test between CNO and saline treatments in Dbh-VLM hM3Dq mice.
(E and F) Injection of CNO increased serum epinephrine and corticosterone levels in adrenalintact (E), but not in adrenalectomized (F), Dbh-VLM hM3Dq mice. ***p < 0.001, n.s., not significant; ventromedial preoptic nucleus ( Figure 5C and Table S1 , n = 5 mice). It is known that the preganglionic neurons of the sympathetic nervous system are located in the spinal IML and the PVN is the head of the hypothalamic-pituitary-adrenal (HPA) axis (Sawchenko and Swanson, 1982; Ulrich-Lai and Herman, 2009) . Given the importance of both the sympathetic nervous system and the HPA axis in stress responses, we examined the precise distribution patterns of spinally and PVN-projecting neurons by injecting Texas red-conjugated dextran amine (MW = 3KD, TR3K), a retrograde tracer, into the PVN or the IML (T8-T11) ( Figure 5D ). We found that the majority of PVN-projecting CA neurons were located in the caudal ventrolateral medulla (CVLM) (Figures 5E, S4C, and S4E) . In contrast, nearly all spinally projecting VLM CA neurons were located in the rostral ventrolateral medulla (RVLM, Bregma À6.8 mm$À6.2 mm) ( Figures 5E, S4D , and S4F). There were few overlapping distributions between spinally projecting neurons and PVN-projecting neurons, suggesting that individual VLM CA neurons appear not to collaterally project to both the PVN and IML.
To further confirm this seeming lack of collateralization, we employed classical dual-color retrograde labeling methods to determine whether individual CA neurons in the VLM are able to project to both the PVN and the IML. A given mouse was injected with two retrograde tracers: Cholera toxin b-subunit conjuncted with Alexa 488 (CTb-488) was injected into the PVN; TR3K was injected into the IML (Figures 5F, S4A , and S4B). We did not detect any TH-immunoreactive neurons (n = 5 mice) in the VLM that had been double-labeled by both CTb-488 and TR3K ( Figures 5G and 5H ). It can therefore be concluded that the distinct projections to the spinal cord and to the PVN arise from two separate populations of VLM CA neurons.
To assess the discreet contributions of the RVLM and the CVLM CA neuron populations to the regulation of hyperglycemia, hM3Dq/mCherry+ was selectively expressed in RVLM CA neurons by delivering a small volume (100 nL) of AAV-DIOhM3Dq-mCherry into the RVLM of Dbh-Cre mice (referred to as Dbh-RVLM hM3Dq mice). The majority of hM3Dq/mCherry+ neurons were located in the RVLM ( Figure S5A , labeled 236 ± 44 neurons in the RVLM and 41 ± 16 hM3Dq/mCherry+ neurons in the CVLM, n = 6 mice, mean ± SEM). Injecting CNO into the Dbh-RVLM hM3Dq mice significantly increased blood glucose levels ( Figure 5I ). Moreover, transection of the thoracic spinal cords of these mice prevented communication between the VLM to the IML, thus blocking the hyperglycemic response ( Figure 5I ). In contrast, after selectively expressing hM3Dq/ mCherry+ in CVLM CA neurons ( Figure S5B , 0 hM3Dq/mCherry+ neurons in the RVLM and 338 ± 23 hM3Dq/mCherry+ neurons in the CVLM, n = 7 mice, mean ± SEM), the injection of CNO did not induce hyperglycemia ( Figure 5J ). These results suggest that CA neurons in the RVLM, but not those in the CVLM, are sufficient to induce hyperglycemia. We performed a Pearson correlation analysis between the number of surviving CA neurons (from the ablation experiments, Figures 1 and 2) and the blood glucose level increase values resulting from LPS challenge. Consistent with results of chemogenetic experiments, this analysis indicated that the increase of blood glucose levels was positively correlated with the number of surviving CA neurons in the RVLM (r = 0.75, p = 0.0005), but not with the number of surviving CA neurons in the CVLM (r = 0.39, p = 0.11) ( Figures S5C and S5D) , suggesting that the CA neurons in the RVLM, but not those in the CVLM, are required for induction of hyperglycemia.
We next asked whether RVLM CA neurons induced hyperglycemia via projections to the spinal cord. A recently developed AAV variant, that enables retrograde access to projection neurons (Tervo et al., 2016 ) was used to selectively express a light-sensitive cation channel ChannelRhodopsin 2 (ChR2) in spinally projecting RVLM CA neurons following the injection of rAAV2-retro-Cre-GFP into the spinal cord and the injection of AAV-DIO-ChR2-mCherry into the RVLM (Figures 5K and 5L) . We found that light stimulation of the spinally projecting RVLM CA neurons rapidly induced hyperglycemia ( Figure 5M ). In contrast, no changes in blood glucose levels were observed when we selectively expressed ChR2 in the VLM CA neurons of Dbh-Cre mice and stimulated the ChR2-expressing CA terminals in the PVN with light ( Figures S5E-S5I ). These results show that RVLM CA neurons increase blood glucose levels via descending projections to the spinal cord rather than via ascending projections to the PVN.
VLM CA Neurons Receive Inputs from Stress-Responsive Neurons
To examine how VLM CA neurons are activated, and to gain a global perspective on the sources of their excitatory inputs, we examined the monosynaptic inputs of these neurons using a Cre-dependent, modified rabies virus-based whole-brain tracing strategy (see STAR Methods) (Wang et al., 2015; Wickersham et al., 2007) . In total, 263 ± 50 (mean ± SEM, n = 4 mice) VLM CA neurons received direct input from 8,915 ± 3,562 (mean ± SEM, n = 4 mice) neurons distributed in 38 brain areas ( Figure 6A ). The strongest labeling was observed in the medulla, including the NTS, the intermediate reticular nucleus, the gigantocellular reticular nucleus, and the medullary reticular nucleus (Figure 6A) . Outside of the medulla, major inputs arose from the lateral parabrachial nucleus (LPB) and the Kö lliker-Fuse nucleus in the pons, from the periaqueductal gray (PAG) and the dorsal raphe nucleus (DRN) in the midbrain, from the PVN and the dorsomedial hypothalamic nucleus (DMH) in the hypothalamus, and from two other areas: the bed nucleus of the stria terminalis (BNST) and the central amygdaloid nucleus (CeA) (Figures 6A and 6B) .
We next examined whether these brain areas provide excitatory inputs to the VLM by injecting CTb-488 into the VLM and AAV-DIO-mCherry into those upstream nuclei of Slc17a6-iresCre mice ( Figure 6C ). Slc17a6 (also known as Vglut2) encodes a glutamate synaptic vesicle transporter VGLUT2 that is expressed in the PVN (Vong et al., 2011) . Hence mCherry was selectively expressed in excitatory neurons. We found many neurons located in the DMH, LPB, DRN, and lateral hypothalamus (LH) were double labeled by CTb488 and mCherry (i.e., glutamatergic) ( Figure 6D ), suggesting that these brain areas provide excitatory inputs to the VLM. In contrast, none of CTb-488 back-labeled neurons in the CeA and BNST were positive for mCherry ( Figures S6D and S6E) . Remarkably, many upstream brain areas of the VLM are well-known stress-related nuclei such as the PVN, LPB, LH, and DMH (Ericsson et al., 1994; Stotz-Potter et al., 1996; Ulrich-Lai and Herman, 2009) .
We verified that these input areas convey stress signals to the VLM. One week following injecting CTb-488 into the VLM, the mice were subsequently subjected to LPS or footshock stress treatments, and Fos expression was examined in CTb-488-labeled neurons. Both LPS and footshock induced the expression of Fos in CTb-488 back-labeled neurons in the PVN and in other stress-related nuclei ( Figures 6E and 6F ), indicating that many VLM-projecting neurons are indeed activated by stress. Collectively, these results strongly suggest that VLM CA neurons integrate stress signals from multiple upstream stress-responsive neurons.
An Excitatory PVN to VLM CA Neuron Circuit that Increases Blood Glucose Levels Given the vast number of studies implying a central role for the PVN in stress responses, we used ChR2-assisted circuit (legend continued on next page) mapping to study the functional effect(s) of the monosynaptic projections from the PVN to VLM CA neurons ( Figure 7A ). PVN-derived ChR2/mCherry-expressing axons were found in the VLM, and axonal swellings were observed to be closely associated with CA neuronal somas ( Figures 7B and 7D) Figure 7H ). Notably, this increase was accompanied by an anorexic effect ( Figure S7H ). In contrast, light stimulation did not induce hyperglycemia in control Slc17a6-PVN mCherry mice ( Figure 7H ). These results suggest that activation of PVN-derived glutamatergic inputs in the VLM is sufficient to induce hyperglycemia. We subsequently examined the necessity of the PVN-VLM circuit in mediating stressinduced hyperglycemia. AAV-DIO-GtACR1-GFP was injected into the PVN of Slc17a6-ires-Cre mice (referred to as Slc17a6-PVN GtACR1 mice) ( Figure 7I ). Optogenetic inhibition of PVNderived glutamatergic nerve endings in the VLM did not impair the stress-induced hyperglycemic response ( Figures 7J-7L) , suggesting that the PVN-VLM circuit may not be essential for stress-induced hyperglycemia. The PVN contains separate populations of neurosecretory neurons that secret different peptide hormones such as oxytocin (Oxt), arginine vasopressin (Avp), thyrotropin-releasing hormone (Trh), and corticotropin-releasing hormone (Crh). To examine whether PVN Crh neurons project to the VLM, CTb-488 was injected into the VLM, and AAV-DIO-mCherry was injected into the PVN of Crh-ires-Cre mice. Crh-ires-Cre mice have Cre recombinase expression in Crh neurons, hence mCherry was selectively expressed in Crh neurons (Taniguchi et al., 2011) . About 10% (168 mCherry neurons in 1,678 CTb-488-labeled neurons, n = 2 mice) CTb-488 back-labeled neurons were mCherry positive (i.e., Crh neurons), suggesting that PVN Crh neurons project to the VLM ( Figure S7A ). Following injection of CTb-488 into the VLM, we examined immunoreactivity of CTb-488 back-labeled neurons to these peptide hormones in the PVN. We found that about 10% of the CTb-488 back-labeled neurons were Oxt-immunoreactive in the PVN (163 Oxt-positive neurons among 1,897 CTb-488 labeled neurons, n = 2 mice) (Figure S7B) . None of the back-labeled VLM-projecting neurons were positive for Avp (0 Avp-positive neurons among 1,680 CTb-488-labeled neurons, n = 2 mice) ( Figure S7C ). To determine whether PVN Trh neurons project to the VLM, we examined Trh mRNA expression in the PVN following injection of rAAV2-hSyn-retro-eGFP into the VLM and found that exceedingly few GFP-positive neurons in the PVN expressed Trh mRNA (2 Trh mRNA-expressing neurons among 1,204 GFP positive neurons, n = 3 mice) ( Figure S7D ). These results appear to exclude the involvement of Avp and Trh neurons in the PVN from PVN-VLM hyperglycemic pathway.
We then injected AAV-DIO-mGFP into the PVN of Crh-ires-Cre or Oxt-ires-Cre (Cre recombinase is expressed in Oxt neurons) (Wu et al., 2012) , which further confirmed that both Crh and Oxt neurons send projections to the VLM ( Figure S7E ). Next, we examined the effects of these projections on blood glucose levels. AAV-DIO-ChR2-mCherry was injected into the PVN of Oxt-ires-Cre or Crh-ires-Cre mice ( Figure S7F ). However, optogenetic activation of axonal projections in the VLM showed that neither Crh nor Oxt projections could induce hyperglycemia ( Figure S7G ), suggesting that these projections maybe affect other functions rather than blood glucose levels.
DISCUSSION
We demonstrate here that VLM CA neurons play a central role in stress-induced hyperglycemia. First, ablation of VLM CA neurons eliminated stress-induced hyperglycemia, whereas activation of these neurons rapidly increased blood glucose levels. Second, RVLM CA neurons induced hyperglycemia via descending projections to the spinal cord in a sympathetic-adrenal-pathway manner. Third, monosynaptic tracing and functional neuroanatomical experiments showed that many stress-responsive nuclei convey stress signals to the VLM. Optogenetic activation of the excitatory projections from the PVN to the VLM resulted in hyperglycemia. Our study demonstrates that VLMmediated circuits control stress-induced hyperglycemia (Figure 7M ) and provides insights into how the brain maintains adequate energy during periods of stress.
VLM CA Neurons Are Required for Both Physical and Psychological Stress-Induced Hyperglycemia Different types of stress activate distinctive patterns of neuronal activation in the brain (Dayas et al., 2001; Herman and Cullinan, 1997; Li et al., 1996) . For example, a comparison of neuronal activation patterns observed in response to acute immune and footshock challenges reveals them to generally be quite distinct (Sawchenko et al., 2000) . However, there might be common nuclei or circuits accounting for a given stress response, regardless of the types of stressors. In agreement with this idea, we found that selective ablation or inhibition of VLM CA neurons blocked the hyperglycemic response to LPS, footshock, and restraint stress. Prior studies have shown the importance of VLM CA neurons in responses to acute cerebral glucose deficit. Selective killing of particular subsets of CA neurons in the hindbrain (e.g., those of the VLM and the LC) can attenuate the hyperglycemic response to the glucoprivic agent 2-DG (Madden et al., 2006; Ritter et al., 2001 ). However, given that VLM CA neurons are widely conserved in mammals, and considering their powerful role in regulating hyperglycemia, it seems unlikely that these neurons only deal with acute, profound glucose deficits that occur very rarely (Ritter et al., 2011) . Although previous studies elegantly highlighted the importance of VLM CA neurons in controlling glucoregulatory responses, the fact that their methods simultaneously ablated a substantial proportion of CA neurons from multiple brain areas made it exceedingly difficult to directly attribute the attenuation of a particular glucoregulatory response to single populations of CA cells. By taking advantage of the improved anatomical precision of recently developed genetic ablation and inhibition techniques, we were here able to identify the essential role of the VLM CA neuronal population in stressinduced hyperglycemia.
Neuronal populations in the hypothalamus have been identified as being crucial for maintaining basal energy metabolism and glucose homeostasis (Morton et al., 2006) . Ablations of hypothalamic neurons dramatically disrupt basal energy metabolism and lead to glycemic disorders (Gropp et al., 2005; Luquet et al., 2005; Zhan et al., 2013) . In contrast with ablation of hypothalamic neurons, ablation of VLM CA neurons did not alter basal blood glucose levels. Our findings support the idea that the hypothalamus and brainstem function differentially in the regulation of energy metabolism.
The LC-CA System Is Dispensable in Mediating Stress-Induced Hyperglycemia Although the LC-CA system is typically viewed as a major component of the centrally mediated fight-or-flight response, our results demonstrate that the LC-CA system is neither essential nor sufficient for initiating stress-induced hyperglycemia. In contrast to VLM CA neurons, which send heavy projections to the HPA axis and the sympathetic nervous system (Kvetnansky et al., 2009; Moore and Bloom, 1979; Rinaman, 2010) , the LC sends intense projections to high cognitive centers such as the hippocampus and the cortex but sends few inputs to the PVN or the spinal cord (Moore and Bloom, 1979; Sawchenko and Swanson, 1982) . Therefore, although the LC-CA system has been implicated in many stress-induced neuropsychiatric disorders such as anxiety, depression, and posttraumatic stress (McCall et al., 2015; Sara, 2009; Southwick et al., 1997; Sun et al., 2015) , the role of the LC-CA system in controlling stress-induced hyperglycemia appears to be indirect or dispensable.
VLM CA Neurons Mobilize Energy Stores via the Sympathetic-Adrenal System
Local microinjection of bicuculline into the VLM induces hyperglycemia (Verberne and Sartor, 2010) . However, the general complexity and the diversity of cell types of the VLM have made it extremely difficult to assign conventional causal pharmacological roles to a specific type of neuron in the VLM. Here, we provided direct evidence that VLM CA neurons are sufficient to induce hyperglycemia.
Two foundational studies showed that VLM CA neurons have axonal projections into the spinal cord and other forebrain regions (Hö kfelt et al., 1973; Kfelt et al., 1974) . However, no studies have provided direct evidence to characterize the (possibly varied) functional roles of projections toward particular regions. Using optogenetic tools in combination with a retrograde AAV variant, we here conclusively establish that the RVLM-spinal circuit is sufficient to induce hyperglycemia.
Increases in the hepatic output of glucose have been proposed as the primary mechanism underlying stress-induced hyperglycemia (Dungan et al., 2009 ). Consistently, we show here that activation of VLM CA neurons resulted in significantly higher hepatic expression of glucose-6-phosphatase (G6pc) and phosphoenolpyruvate carboxykinase 1 (Pepck), two key genes that regulate glycogenolysis and gluconeogenesis ( Figure S2B ). See also Figure S6 and Table S1 . (E-G) PVN glutamatergic neurons provide monosynaptic inputs to VLM CA neurons. Raw traces of whole-cell recordings (E) show that the excitatory postsynaptic currents (EPSCs) evoked by light stimulation (blue bar, 5 ms) (1) were abolished by application of the AMPA-type glutamate receptor blocker DNQX (10 mM) (2), and the currents can be partially impaired by washing with aCSF (3), demonstrating that the observed evoked-currents are glutamatergic in nature. (F) shows a time-series plot of the EPSC amplitude draw data from one representative cell, and (G) shows group data (n = 7 cells). All recordings were performed during the application of TTX (10 mM) and 4-AP (1 mM), demonstrating that VLM CA neurons received monosynaptic input from PVN. **p < 0.01, paired Student's t test. (H) Light stimulation (5-ms duration, 20 Hz, 1 s on, 1 s off for 1 hr, horizontal bar) of PVN-derived glutamatergic nerve endings in the VLM rapidly increased blood glucose levels. *p < 0.05, ****p < 0.0001. Two-way ANOVA analyses followed by Bonferroni's post hoc test between Slc17a6-PVN ChR2 and Slc17a6-PVN Therefore, VLM-mediated hyperglycemia may be predominantly resulted from the breakdown of hepatic glycogen ( Figure 7M ). RVLM CA neurons are known to regulate a range of unique autonomic functions Ritter et al., 2006) . Abbott et al. demonstrated that optogenetic activation of RVLM CA neurons in conscious mice increased breathing rates and affected cardiorespiratory functions ; other studies have shown the influences of RVLM CA neurons on glucoprivic responses and arterial pressure (Madden et al., 2006; Ritter et al., 2001) . Electrophysiological recording in the RVLM has identified at least two types of RVLM CA neurons with different axonal conduction velocities (Schreihofer and Guyenet, 1997) . Verberne et al. found that RVLM neurons that respond to 2-DG administration are not barosensitive, whereas RVLM barosensitive neurons were either unaffected or slightly inhibited by 2-DG administration (Verberne and Sartor, 2010) . Additionally, our retrograde tracing results establish that there are at least two separate populations of RVLM CA neurons: PVN-projecting neurons and spinally projecting neurons. Although it is unclear whether the neurons and circuits characterized in the present study may have the capacity to control other functions, a preponderance of evidence suggests subpopulations of RVLM CA neurons probably function differentially in controlling autonomic responses.
The Upstream Inputs into VLM CA Neurons
The VLM CA neuronal population, in particular the rostral part (i.e., RVLM), has been proposed to function as an emergency center in the brain . A recent work showed that RVLM CA neurons were necessary and sufficient for stressinduced ischemia-reperfusion protection, which elegantly highlights the importance of these neurons in dealing with emergency (Abe et al., 2017) . In support of the ''emergency center'' hypothesis for VLM CA neurons, our monosynaptic retrograde tracing study showed that these neurons receive direct inputs from multiple stress-related nuclei, suggesting that VLM CA neurons do indeed occupy a key position for the integration of stress signals.
We found that the PVN is a nucleus of stress signaling that functions upstream of the VLM to inhibit food intake and cause hyperglycemia. The role of the PVN in controlling appetite is now well established. For example, subsets of PVN glutamatergic neurons provide excitatory inputs to agouti-related protein neurons in the arcuate nucleus and thereby drive hunger (Krashes et al., 2014) . Whereas selective suppression of PVN axon projections to the vlPAG/DRN elicited feeding (Stachniak et al., 2014) , food intake was suppressed following the activation of the PVN-LPB (Garfield et al., 2015) . Beyond appetite and feeding, Kalsbeek et al. demonstrated that pharmacological activation of PVN neurons can cause hyperglycemia (Kalsbeek et al., 2004) , although the precise circuitry through which the PVN induces hyperglycemia has remained obscure. The present study helps to clarify this, as we show that the PVN-VLM circuit is necessary for the induction of hyperglycemia.
Following endotoxin treatments, the peripheral immune system can activate the NTS via the afferent vagus (Ek et al., 1998) , which then activates downstream areas to trigger behavioral and physiological responses (Ericsson et al., 1994) . The NTS sends heavy projections to the PVN (Rinaman, 2010) , which may ultimately relay stress signals to the VLM. Alternatively, the NTS is also known to send direct inputs to the VLM (Sawchenko and Swanson, 1982) . Therefore, consistent with the assumption that stress signals may activate VLM CA neurons via multiple circuits, the PVN-VLM circuit is sufficient, but not necessary, to induce hyperglycemia.
Stress-related glycemic disorders increase many health risk factors for both diabetics and non-diabetic people (Bradley, 1988; McCowen et al., 2001) . For example, stress-induced hyperglycemia is frequently observed in critically ill patients and likely contributes to poor clinical outcomes (Capes et al., 2000; Dungan et al., 2009) . Intensive insulin therapy is often used for strict control of blood glucose levels in intensive care units, but this carries the risk of inducing hypoglycemic episodes (Marik and Bellomo, 2013; Xiu et al., 2014) . Our study establishes that blood glucose levels during stress are tightly controlled by VLM CA neurons and identifies the particular neural circuits that function in this regulatory process.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
were in a 3 0 to 5 0 orientation relative to the promoter. All AAV vectors were packaged into 2/9 serotypes in the laboratory of Dr. Minmin Luo (NIBS, Beijing) with the assistance of Dr. Dong Duan (University of Missouri) (Duan et al., 2001) . Final viral vector titers were >10 9 particles/ml.
The initial rabies viruses SAD-OG-mCherry(EnvA) and the cell line were kindly provided by Dr. Edward M. Callaway (Salk Institute). The rabies viruses and the other two helper virus were produced and concentrated commercially by BrainVTA of Wuhan, China.
Stereotaxic virus and tracer injections
Mice were anesthetized with pentobarbital (80 mg/kg; IP) and placed in a temperature-controlled stereotaxic holder. A small hole was opened in the skull. Pulled glass pipettes ($20 mm tip diameter) were filled with virus and inserted into the target areas. Viral vectors were injected into the brain under pressure (infusion speed = 23 nl/minute) (Nanoliter 2000 Injector, WPI). To selectively kill particular subpopulations of catecholaminergic (CA) neurons, a Cre-dependent AAV-flex-taCasp3-TEVp vector (800-1000 nl) was bilaterally infused into the LC (coordinate AP/DV/ML: -5.5/-2.6/ ± 1.0 mm), NTS, For cell-type-specific anterograde tracing, a viral tracer, AAV-DIO-mGFP (300 nl), was injected into the VLM of DBH-Cre mice. For retrograde tracing, tract tracers (0.1% Alexa Fluor 488 conjugated Cholera Toxin Subunit B, CTb-488, Catalog No. C34775; 5% Texas Red conjugated dextran amine, TRDA, MW = 3 KD, TR3K, Catalog No. D3328; ThermoFisher) were unilaterally injected into the PVN or the spinal cord (coordinate AP/DV/ML: T8-T11/-0.5/ ± 0.3 mm). Post-surgery, mice were caged individually and allowed to recover for at least 2 weeks before any studies were performed.
The modified rabies virus based three-virus system was used for mapping the whole-brain inputs to VLM CA neurons (Wickersham et al., 2007) . Equal volumes of AAV-DIO-TVA-EGFP and AAV-DIO-G were mixed and then $200 nL of the AAV mixture was unilaterally injected into the VLM of Dbh-Cre mice. Two weeks later, the rabies virus SAD-DG-mCherry(EnvA) (300 nl), which lacks the rabies glycoprotein (G) gene and was pseudotyped with the avian sarcoma leucosis virus envelope protein (EnvA), was injected into the same location in a biosafety level-2 lab facility ( Figures S6A and S6B ). Starter neurons were characterized by the coexpression of RV-mCherry and TVA-EGFP, which were restricted in the VLM ( Figure S6C ). Following one week of viral replication and trans-synaptic spread, mouse brains were prepared for further analysis.
For selectively stimulating spinally-projecting RVLM CA neurons, rAAV2-CMV-retro-Cre-eGFP (Taitool, Shanghai) was injected into the spinal cord (T8-T11), and AAV-DIO-ChR2-mCherry was injected into the RVLM.
Glucose, corticosterone, and epinephrine measurement To measure blood glucose, the ends of mouse tails were cut horizontally with a razor blade and a small drop of blood was collected with gentle massage. Glucose levels were then measured using a blood glucose meter (One touch, Johnson & Johnson Medical) . Basal blood glucose levels were first measured at the onset of the dark phase of the photoperiod. Following stress treatments or injections of CNO (Catalog No. BML-NS105-0025, Enzo, 1 mg/kg bodyweight in saline, IP), LPS (Catalog No. L2880, Sigma, 10 ug /kg bodyweight in saline, IP), or saline, blood glucose levels were measured at various time points. No food was supplied during the blood glucose measurement period.
For serum assays, 60 min after the injection of LPS, CNO, or saline, blood was drawn from the retrobulbar intraorbital capillary plexus, and serum was then separated by centrifugation (13,000 rpm for 15 min). Commercial ELISA kits were used for measuring serum corticosterone (Catalog No. ADI-900-097, ENZO Life Science) and epinephrine (Catalog No. KA3837, Abnova) levels. Glucose, corticosterone, and epinephrine measurements were independently replicated by two testers.
Real-time PCR Animals were deeply anesthetized 90 min following the injection of CNO or saline. Livers were rapidly dissected and stored in liquid nitrogen. Total RNA was extracted using Trizol reagent (Catalog No. 15596-026, Life Technologies) . Total RNA (1 mg) was reverse transcribed into cDNA using PrimeScript RT Master Mix (Perfect Real Time, Catalog No. RR036A, Takara). Gene expression levels were then analyzed using a BioRad CFX96 real-time PCR detection system (Bio-Rad Laboratories) and the expression levels of target genes were normalized to Gapdh RNA expression.
Optogenetic experiments
For optogenetic experiments, a small craniotomy was made in the skull. AAV-DIO-ChR2-mCherry vectors (1000 nl) or AAV-DIOGtACR1-GFP vectors (1000 nl) were bilaterally delivered into target areas, and then an optical fiber (200 mm in diameter, NA = 0.39) was inserted into same locations and affixed to the skull with dental cement. For optogenetic activation, blue laser pulses (473 nm wavelength, 5 ms pulse duration, 20 Hz frequency, 1 s on and 1 s off; 20 mw continuous output power measured at the fiber
QUANTIFICATION AND STATISTICAL ANALYSIS
All quantifications were performed not blinded. Statistical analyses were performed using Graphpad prism 6 and Excel. Statistical details including the definitions and exact value of n (e.g., number of animals, number of neurons, etc), deviations, p values, and the types of the statistical tests can be found in the Figures and Figure Legends . All statistical comparisons were conducted on data originating from two or more biologically independent experimental replicates. All data are shown as means ± SEM. Two group comparisons were analyzed using two-tailed Student's t test. Comparisons between groups with two or more factors were analyzed using two-way ANOVA, followed by Bonferroni's post hoc test. p < 0.05 was considered significant. * indicates p < 0.05, ** p < 0.01, and *** p < 0.001, **** p < 0.0001. Correlations were computed using Pearson's correlation coefficient.
Further requests for data used in this study can be directed to the corresponding author.
